Selective Chromosomal Damage and Cytotoxicity of 125I-labeled Monoclonal Antibody 17-la in Human Cancer Cells

Cancer Research

Volumn 49, Issue 11, 1989, Pages 2952-2958

  Woo, David V ^a   Li, Derui ^a   Mattis, Jeffrey A ^b   Steplewski, Zenon ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Centocor Inc   (Jamaica)

^c WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDRECOLOMAB; IODINE 125; RADIOISOTOPE; TUMOR ANTIGEN;

CELL CULTURE; CHROMOSOME DAMAGE; COLON CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELL SURVIVAL; CHROMOSOME ABERRATIONS; COLONIC NEOPLASMS; DNA DAMAGE; DNA, NEOPLASM; HUMAN; IODINE RADIOISOTOPES; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0024340011     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mach, J., Carrel, S., Forni, N., Ritschard, J., Donath, A., and Alberto, P. Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. N. Engl. J. Med., 303:5–10, 1980.
2. Larson, S. M., Brown, J. P., Wright, P. W., Carrasquillo, J. A., Hellstrom, I., and Hellstrom, K. E. Imaging of melanoma with 1–131-labeled monoclonal antibodies. J. Nucl. Med., 24:123–129, 1983.
3. Halpern, S., Dillman, R. O., Witztum, K. F., Shega, J. F., Hagan, P. L., Burrows, W. M., Dillman, J. B., Clutter, M. L., Sobol, R. E., Frincke, J. M., Bartholomew, R. M., David, G. S., and Carlo, D. J. Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report. Radiology, 155:493–499, 1985.
4. Hofer, K. G., and Hughes, W. L. Radiotoxicity of intranuclear tritium, 125iodine, and 13liodine. Radiat. Res., 47:94–109, 1971.
5. Bradley, E. W., Chan, P. C., and Adelstein, S. J. The radiotoxicity of iodine-125 in mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA. Radiat. Res., 64:555–563, 1975.
6. Chan, P. G., Lisco, E., Lisco, H., and Adelstein, S. J. The radiotoxicity of iodine-125 in mammalian cells. II. A comparative study on cell survival and cytogenetic responses to 125IUdR, 131IIUdR and 3HtdR. Radiat. Res., 67: 332–343, 1976.
7. Martin, R. F., and Haseltine, W. A. Range of radiochemical damage to DNA with decay of iodine-125. Science (Wash. DC), 213:896–898, 1981.
8. Bloomer, W. D., and Adelstein, S. J. 5-(25I)-Iododeoxyuridine and the Auger effect: Biological consequences and implications for therapy. Pathobiol. Annu., 8:407, 1978.
9. Warters, R. L., Hofer, K. G., and Harris, C. R. Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site for radiation damage. Curr. Top. Radiat. Res. Q., 12:389, 1977.
10. Herlyn, M., Steplewski, Z., Herlyn, D., and Koprowski, H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 76:1438–1442, 1979.
11. Koprowski, H., Steplewski, Z., Mitchell, K., Herlyn, M., Herlyn, D., and Fuhrer, J. P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somat. Cell Genet, 5:957–972, 1979.
12. Herlyn, D., Powe, J., Alavi, A., Mattis, J. A., Herlyn, M., Ernst, C., Vaum, R., and Koprowski, H. Radioimmunodetection of human tumor xenografts by monoclonal antibodies. Cancer Res., 43:2731–2735, 1983.
13. Sears, H. F., Mattis, J., Herlyn, D., Hayry, P., Atkinson, B., Ernst, C., Steplewski, Z., and Koprowski, H. Phase I clinical trial of monoclonal antibody in treatment of gastrointestinal tumors. Lancet, 2:762–765, 1982.
14. Sears, H. F., Steplewski, Z., Herlyn, D., and Koprowski, H. Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma. J. Biol. Response Modif., 3:138–150, 1984.
15. Boven, E., Lindmo, T., Mitchell, J. B., and Bunn, P. A., Jr. Selective cytotoxicity of 125I-labeled monoclonal antibody T101 in human malignant T cell lines. Blood, 67:429–435, 1986.
16. Lindmo, T., Boven, E., Mitchell, J. B., Morstyn, G., and Bunn, P. A., Jr., Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody. Cancer Res., 45:5080–5087, 1985.
17. Sugiyama, Y., Chen, F. A., Takita, H., and Bankert, R. B. Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gpl60 by 125I-labeled anti-gpl60 monoclonal antibody. Cancer Res., 48: 2768–2772, 1988.
18. Leibovitz, A., Stinson, J. C., McCombs, W. B., III, McCoy, C. E., Mazur, K. C., and Mabry, N. D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res., 36:4562–4569, 1976.
19. Magnani, J. L., Steplewski, Z., Koprowski, H., and Ginsburg, V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19–9 in the sera of patients as a mucin. Cancer Res., 43:5489–5492, 1983.
20. Khaw, B. A., Mattis, J. A., Melincoff, G., Strauss, H. W., Gold, H. K., and Haber, E. Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction. Hybridoma 3:11–23, 1984.
21. Markwell, M. A. K., and Fox, C. F. Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using l,3,4,6-tetrachloro-3a,6a-di-phenylglycoluril. Biochemistry, 17:4807–4817, 1978.
22. Kassis, A. I., Adelstein, S. J., and Bloomer, W. D. Therapeutic implications of Auger-emitting radionuclides. In: R. P. Spencer, R. H. Seevers, Jr., and A. M. Friedman (eds.), Radionuclides in Therapy, pp. 119–134. Boca Raton, FL: CRC Press, Inc., 1988.
23. Krisch, R. E. Lethal effects of iodine-125 decay by electron capture in Escherichia coli and bacteriophage T1. Int. J. Radiat. Biol., 21: 167–189, 1972.
24. Magnani, J. L., Brockhaus, M., Smith, D. F., Ginsburg, V., Blaszcczyk, M., Mitchell, K. F., Steplewski, Z., and Koprowski, H. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science (Wash. DC), 212:55–56, 1981.
25. Bloomer, W. D., McLaughlin, W. H., Weichselbaum, R. R., Hanson, R. N., Adelstein, S. J., and Seitz, D. E. The role of subcellular localization in assessing the cytotoxicity of iodine-125 labelled iododeoxyuridine, iodota-moxifen, and iodoantipyrine. J. Radioanal. Chem., 65:209–221, 1981.
26. Bloomer, W. D., McLaughlin, W. H., Weichselbaum, R. R., Tonnesen, G. L., Hellman, S., Seitz, D. E., Hanson, R. N., Adelstein, S. J., Rosner, A. L., Burstein, N. A., Nove, J. J., and Little, J. B. Iodine-125-labeled tamoxifen is differentially cytotoxic to cells containing oestrogen receptors. Int. J. Radiat. Biol., 38:197–202, 1980.